Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease

The emergence of new and resistant viruses is a serious global burden. Conventional antiviral therapy with small molecules has led to the development of resistant mutants. In the case of hand, foot and mouth disease (HFMD), the absence of a US-FDA approved vaccine calls for urgent need to develop an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalani, Salima, Gew, Lai Ti, Poh, Chit Laa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648656/
https://www.ncbi.nlm.nih.gov/pubmed/33171280
http://dx.doi.org/10.1016/j.peptides.2020.170443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648656/
https://www.ncbi.nlm.nih.gov/pubmed/33171280
http://dx.doi.org/10.1016/j.peptides.2020.170443

Ejemplares similares